Nabriva Therapeutics plc Business Operations Contracts & Agreements

17 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to API Supply Agreement, dated November 11, 2022, by and between Nabriva Therapeutics Ireland Designated Activity Company and Hovione Limited
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2023
Third Amendment to Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2022
Side Agreement to Manufacturing Services Agreement, dated November 19, 2021, by and among Nabriva Therapeutics Ireland DAC and Patheon UK Ltd
Services Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2022
First Amendment to API Supply Agreement, dated August 4, 2021, by and between Nabriva Therapeutics Ireland Designated Activity Company and Hovione Limited
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Second Amendment to Sales Promotion and Distribution Agreement, dated as of April 12, 2021, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2021
First Amendment to Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2021
Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International GmbH and Merck...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2020
Active Pharmaceutical Ingredient Supply Agreement by and between Nabriva Therapeutics Ireland DAC and Hovione Limited, dated as of November 23, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2019
Agreement for the Commercial Supply of Products by and between Arran Chemical Company Limited and Nabriva Therapeutics Ireland DAC, dated as of November 12, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2019
Packaging and Supply Agreement by and between Sharp Corporation and Nabriva Therapeutics US, Inc., dated as of August 30, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2018
Manufacturing and Supply Agreement by and between Zavante Therapeutics, Inc. and Fisiopharma, S.r.l., dated as of April 14, 2017
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Amended and Restated Pharmaceutical Manufacturing and Exclusive Supply Agreement by and between Laboratorios ERN, S.A. and Zavante Therapeutics, Inc. dated as of July 28, 2016, as...
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Manufacturing and Supply Agreement by and between Zavante Therapeutics, Inc. and Ercros, S.A., dated as of July 28, 2016
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Controlled Equity OfferingSM Sales Agreement, dated March 16, 2018, by and between Nabriva Therapeutics plc and Cantor Fitzgerald & Co
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2018
Key Intermediate Supply Agreement, dated of August 28, 2017 by and among Nabriva Therapeutics Ireland DAC, and SEL Biochem Xinjiang Co., Ltd, and Fountain International...
Development Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Master Agreement for the Manufacture, Packaging and Supply of Products, dated August 7, 2017, by and between ALMAC Pharma Services Limited and Nabriva Therapeutics Ireland DAC
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2018
Manufacturing Services Agreement, dated May 8, 2017, by and between Patheon UK Limited and Nabriva Therapeutics AG
Services Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018